Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Oct 22;10:2265–2275. doi: 10.2147/COPD.S90948

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2015 Rhee et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License

The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Clinical intention-to-treat analysis of the changes of EXACT-PRO and CAT scores.

Notes: The EXACT-PRO (A) and CAT scores (B) decreased significantly compared with those on D1 (*P<0.05, **P<0.01 vs D1) in both the zabofloxacin and moxifloxacin groups. The decline in the EXACT-PRO (C) scores on D6 and D7 and the decline in the CAT scores (D) on D5, D6, D7, and D36 were significantly greater in the zabofloxacin than in the moxifloxacin group (*P<0.05 and **P<0.01 between the zabofloxacin and moxifloxacin groups).

Abbreviations: EXACT-PRO, EXAcerbations of Chronic Pulmonary Disease Tool-Patient-Reported Outcome; CAT, chronic obstructive pulmonary disease assessment test; D, day.